Shanghai, China

Jinxue He



 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Jinxue He: Innovator in Pharmaceutical Chemistry

Introduction

Jinxue He is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds and their applications in drug development. With a total of 2 patents, He has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

His latest patents include the following:

1. **Triazolopyrimidine compound and salt, composition and use thereof** - This patent relates to triazolopyrimidine compounds and salts, which exhibit good activity and high selectivity for NAE. The compounds are represented by a specific formula, showcasing their potential in therapeutic applications.

2. **2-arylbenzofuran-7-formamide compounds, preparation method and use thereof** - This invention provides a 2-arylbenzofuran-7-formamide compound, along with its preparation method and use in developing anti-tumor drugs. The compound's structure allows for various substituents, enhancing its pharmacological properties.

Career Highlights

Jinxue He has worked with esteemed organizations such as the Chinese Academy of Sciences and Cisen Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

He has collaborated with notable colleagues, including Zehong Miao and Chunhao Yang. These partnerships have further enriched his research and innovation efforts.

Conclusion

Jinxue He is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and advancements in drug development. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…